Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions Sells ProGest Unit to University of Calgary

NEW YORK, Oct. 24 - Genomic Solutions has sold one of its Investigator ProGest protein digestion station to the University of Calgary, the company said on Wednesday.

Although Genomic Solutions did not disclose the purchase price of the device, it said the unit is a “major system” that is worth “$25,000 or more.”

The neuroscience research group from the university’s department of physiology and biophysics purchased the ProGest, which automates the digestion of proteins in gel plugs, according to Genomic Solutions. The school currently owns other Investigator products, including a 2-D electrophoresis system and a ProPic robotic workstation, the Ann Arbor, Mich.-based company said.

Earlier this month, in an effort to trim costs, the microarray and proteomics company sold off its proteomics contract services business to a newly formed company, Proteomic Research Services.

"This action will significantly reduce our cost structure with minimal lost revenue impact," Jeffrey Williams, CEO of Genomics Solutions, said in a statement on Oct. 3. "Our 2000 revenue associated with proteomic contract services was less than 5 percent of sales." 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.